Pfizer Warns of Lung Cancer With Inhaled Insulin
NEW YORK (Reuters) - Pfizer Inc <PFE.N> and Nektar
Therapeutics <NKTR.O> said on Wednesday clinical trials of the
inhaled insulin Exubera found increased cases of lung cancer,
leading Nektar to stop seeking a marketing partner for the
troubled product and abandon it.
